Updated results from Pfizer’s late-stage study of its coronavirus vaccine show the two-dose shot’s overwhelming protection is holding up six months after the second dose.
Coronavirus
Business Insider: Pfizer’s COVID-19 shot remains highly protective against the coronavirus
A health worker holds a vial of Pfizer-BioNTech vaccine against the coronavirus at a vaccination centre set up at the Dubai International Financial Center in the Gulf emirate of Dubai, on Feb. 3, 2021.
